Original language | English (US) |
---|---|
Pages (from-to) | S308 |
Journal | Annals of Oncology |
Volume | 33 |
DOIs | |
State | Published - 2022 |
P-163 Tyrosine kinase inhibitors (TKIs) plus transarterial chemoembolization (TACE) compared to TACE alone as downstaging therapy in transplant recipients with hepatocellular carcinoma: Abstract Book of the ESMO 24th World Congress on Gastrointestinal Cancer 2022, Barcelona, Spain, 29 June -2 July 2022
A. Esmail, S. Kodali, E. Graviss, D. Nguyen, L. Moore, A. Saharia, A. Uosef, D. Victor, M. Abdelrahim
- Houston Methodist
- Academic Institute
- Department of Medicine
- Dr. Mary and Ron Neal Cancer Center
- Underwood Center for Digestive Health
- Houston Methodist Hospital
- Weill Cornell Medical College
- Department of Pathology & Genomic Medicine
- Center for Infectious Diseases
- Department of Surgery
- J.C. Walter Jr. Transplant Center
- Center for Health Data Science and Analytics
- Immunobiology & Transplant Science Center
- Sherrie and Alan Conover Center for Liver Disease & Transplantation
Research output: Contribution to journal › Article › peer-review